Inventor · disambiguated record
Dongqi Chen
Also filed as: CHEN DONGQI
3 granted patents·8 pending applications·0 citations·filing 2020–2025
42Inventor score
Top patents by PatentIndex Score
11 records- 0163US2024058337A1Managing Side Effects in T Cell TherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2023·Application pending·0 cites
- 0261US2024075061A1Cell therapy activating lymphocyte in tmeINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Application pending·0 cites
- 0361US2024299452A1Rapamycin and Cell TherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2024·Application pending·0 cites
- 0459US12043654B2Anti-GCC antibody and CAR thereof for treating digestive system cancerINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Granted Jul 23, 2024·0 cites·21 claims
- 0559US11833174B2Modified cell with enhanced functionality and cellular therapy thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Dec 5, 2023·0 cites·17 claims
- 0656US2025038075A1Chip and preparation method thereof, and electronic deviceHUAWEI TECH CO LTD·Filed 2024·Application pending·0 cites
- 0755US11858977B2Modified TCR and uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Jan 2, 2024·0 cites·18 claims
- 0852US2024024476A1CAR Cells and Polyspecific Binding Molecules for Treating Solid TumorINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Application pending·0 cites
- 0950US2021024890A1Modulating t cell function and responseINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Application pending·0 cites
- 1050US2023293691A1Cell/gene therapies targeting mage-a4 peptideINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Application pending·0 cites
- 1147US2025339558A1Recombinant Viral Particle for Gene and/or Cellular TherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dongqi Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →